CHEK2 and colorectal carcinoma: For instance, cisplatin increases sensitivity in lung and colorectal carcinoma cells under serum deprivation conditions by enhancing the activation of the ataxia telangiectasia mutated (ATM)/checkpoint kinase 2 (Chk2)/P53 signaling axis relative to normal culture conditions [25].